thebusinessmagazine4h
Oxford Biomedica rebrands as OXB amid business transformation
Oxford Biomedica has rebranded as OXB to reinforces the firm’s transformation into a global pure-play cell and gene therapy ...
Health Rounds: Breastfeeding is safe for breast cancer survivors
Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.
Posts Sharing Mpox Misinformation Recycle Claims from Prior Viral Outbreaks
Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...
MARKET REPORT: St Tropez maker burnt by Nigerian currency woes
The stock fell 15% after the consumer goods firm swung to a loss of £96m for the 12 months to the end of May, against a £62m ...
Managed Healthcare Executive11h
FDA Approves Fasenra for Treatment of Eosinophilic Granulomatosis with Polyangiitis
More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.
ENDPOINTS NEWS12h
FDA ap­proves As­traZeneca’s asth­ma med­ica­tion Fasen­ra to treat rare au­toim­mune con­di­tion
A few months after a key label expansion, AstraZeneca’s asthma treatment Fasenra has received FDA approval to treat a rare ...
MedPage Today14h
FDA OKs New Option for Rare Immune-Mediated Vasculitis
EGPA, previously known as Churg-Strauss syndrome, is a rare inflammatory disorder characterized by asthma, necrotizing ...
prmoment.com19h
Good and Bad PR: AstraZeneca’s good robot, Murdoch goes wrong with Rightmove and Asos keeps schtum on returns
The first Christmas campaigns started in earnest last week, so it must be September. Murdoch makes money moves Rightmove ...
FiercePharma19h
AstraZeneca's Fasenra plays catch-up with GSK's Nucala, gaining FDA nod for rare autoimmune disease
Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart to treat patients with severe asthma, the IL-5 ...
Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins Omega Funds
The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...
The Gallery Backyard BBQ & Griddle on MSN21h
Masterbuilt Gravity XT _ I Ran My Masterbuilt Gravity XT on OAK SPLITS and This is What Happened
Pump up your shoulders and chest in 15 minutes with this simple 3-move workout Donald Trump Suffers Major Blow in Top ...
GlobalData on MSN23h
Pfizer and AstraZeneca debate: when “the greater good” matters
When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make ...